about
Complex architecture and regulated expression of the Sox2ot locus during vertebrate developmentLong noncoding RNAs in mouse embryonic stem cell pluripotency and differentiationSignaling Pathways in MelanogenesisKeeping abreast with long non-coding RNAs in mammary gland development and breast cancerEpigenetic regulation in human melanoma: past and futureSNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancerRelationships between signaling pathway usage and sensitivity to a pathway inhibitor: examination of trametinib responses in cultured breast cancer linesPotentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell LinesA transcriptional sketch of a primary human breast cancer by 454 deep sequencingRegulated post-transcriptional RNA cleavage diversifies the eukaryotic transcriptome.Emerging role of long non-coding RNA SOX2OT in SOX2 regulation in breast cancerHormone Resistance in Two MCF-7 Breast Cancer Cell Lines is Associated with Reduced mTOR Signaling, Decreased Glycolysis, and Increased Sensitivity to Cytotoxic Drugs.In vitro analysis of breast cancer cell line tumourspheres and primary human breast epithelia mammospheres demonstrates inter- and intrasphere heterogeneity.Accommodating the bacterial decoding release factor as an alien protein among the RNAs at the active site of the ribosome.Evidence That GRIN2A Mutations in Melanoma Correlate with Decreased Survival.Evidence for the existence of triple-negative variants in the MCF-7 breast cancer cell population.The Regulatory Role of Long Noncoding RNAs in Cancer Drug Resistance.Regulated expression of PTPRJ/CD148 and an antisense long noncoding RNA in macrophages by proinflammatory stimuli.Correction: Sarkar, D., et al. Multiple Isoforms of ANRIL in Melanoma Cells: Structural Complexity Suggests Variations in Processing. Int. J. Mol. Sci. 2017, 18, 1378.
P50
Q24651231-AD66D53E-C337-4C80-976E-6EDB102DB584Q24655701-FF01B7DB-5FC9-4CF5-BFBB-B71C86930585Q26739678-F49FD600-8EB9-4608-BBDC-0275098CE581Q26849813-E033A9AA-875E-4310-9953-27E7CD694979Q28085681-599B701B-17C9-443C-BF08-DB0884511445Q28308175-E2E192FB-0AB8-4316-B8B9-31DED8C311B1Q28542662-C8E01F51-4A35-484D-96BF-2A30B26993D0Q28546221-F9EAD424-FF1F-4FA9-A0EF-8C83885386AAQ33432300-70E8297A-370D-43FE-A4E7-B7479BA61851Q33736486-7F8BCFC0-AB40-4B2B-B240-16B87F9CD6E0Q33875325-2F3EB633-D28B-4CAF-8F3A-16EAF364A9E4Q34125846-C10A9A1F-A340-444D-8151-56AA1F4E8204Q34764103-97EFD794-100D-4076-A0AE-0F8C580C544DQ36875497-D82E83CD-04BE-4193-AE44-3F0270D883C8Q37466867-602FF7B4-4578-4C68-B8D9-F09EB1CB09BCQ37650374-41B8BF46-B025-447B-B65D-A700D35972B8Q38748127-EB6E44E4-FCEE-420D-BEED-D0FDD0DA019CQ39127963-EDF67029-3576-4E92-8ED1-50F2F23098A0Q53069058-D86C15EF-C54D-4614-9A61-558F99AE2BA9
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marjan Askarian-Amiri
@ast
Marjan Askarian-Amiri
@en
Marjan Askarian-Amiri
@es
Marjan Askarian-Amiri
@nl
type
label
Marjan Askarian-Amiri
@ast
Marjan Askarian-Amiri
@en
Marjan Askarian-Amiri
@es
Marjan Askarian-Amiri
@nl
prefLabel
Marjan Askarian-Amiri
@ast
Marjan Askarian-Amiri
@en
Marjan Askarian-Amiri
@es
Marjan Askarian-Amiri
@nl
P1053
F-7910-2010
P106
P2798
P31
P496
0000-0003-3524-9626